Julia Tchou

Available models for breast cancer risk assessment: how accurate are they?

Acceptance of tamoxifen chemoprevention by physicians and women at risk.

Diffuse optical measurement of blood flow in breast tumors.

Barriers to rehabilitation following surgery for primary breast cancer.

Biopsy findings after breast conservation therapy for early-stage invasive breast cancer.

Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States.

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.

Mammographic appearance of recurrent breast cancer after breast conservation therapy.

Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast cancer.

Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography.

Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer.

Computer aided automatic detection of malignant lesions in diffuse optical mammography.

Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.

The ethnic divide in breast reconstruction: a review of the current literature and directions for future research.

Mesothelin, a novel immunotherapy target for triple negative breast cancer.

Challenges in the clinical utility of the serum test for HER2 ECD.

Breast reconstruction in bilateral prophylactic mastectomy patients: factors that influence decision making.

Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles.

Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm.

Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy.

The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design.

Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.

Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging.

Isoform level expression profiles provide better cancer signatures than gene level expression profiles.

Redox imaging of human breast cancer core biopsies: a preliminary investigation.

Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS.

Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step.

Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema.

Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.